ANNOUNCED ONGOING Drug recall · Reported 1 Oct 2026 · FDA company announcement, classification pending
Greewich Glutathione Injection recalled by Greenwich Rx
Greenwich Rx is recalling Greewich Glutathione Injection, distributed nationwide in the US. The recall was initiated on 1 Oct 2026 and is listed as ongoing.
Recall details
- Recall number
- FDA-PR-72e3927420c1
- Recalling firm
- Greenwich Rx
- Brand
- Greewich
- Classification
- Pending
- Status
- Ongoing
- Recall initiated
- 1 Oct 2026
- Reported
- 1 Oct 2026
- Reason category
- Packaging Defects
- Drug class
- Injectable & IV Drugs
Timeline
| 1 Oct 2026 | Recall initiated by company | |
| 1 Oct 2026 | Published in enforcement report | +0 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Potential elevated endotoxin levels. IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels. Risk Statement: There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death. To date, Greenwich Rx has received two reports involving patients who received emergency department care following intravenous (IV) administration of a glutathione product that was not formulated for IV use. Glutathione is a naturally occurring antioxidant that helps protect cells from oxidative stress. The voluntary recall affects the following lots of compounded glutathione 200 mg/mL dispensed in 10mL multidose vials and intended for subcutaneous injection: Product Strength Package Size Lot Number Beyond Use Date GlutathioneInjection 200 mg/mL 10mL 0060-062426-1 10/02/2026 0060-062726-1 10/05/2026 0060-070926-1 10/17/2026 0060-071426-1 10/22/2026 0060-071426-2 10/22/2026 0060-072026-1 10/28/2026 0060-072726-1 11/04/2026 0060-072926-1 11/06/2026 0060-073126-1 11/08/2026 0060-080426-1 11/12/2026 The glutathione was distributed to patients nationwide between June 26, 2026, and September 21, 2026. Refer to the photo of the product label below for the location of lot number and beyond use date. G
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the company
Greewich Glutathione Injection
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Potential elevated endotoxin levels. IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels. Risk Statement: There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death. To date, Greenwich Rx has received two reports involving patients who received emergency department care following intravenous (IV) administration of a glutathione product that was not formulated for IV use. Glutathione is a naturally occurring antioxidant that helps protect cells from oxidative stress. The voluntary recall affects the following lots of compounded glutathione 200 mg/mL dispensed in 10mL multidose vials and intended for subcutaneous injection: Product Strength Package Size Lot Number Beyond Use Date GlutathioneInjection 200 mg/mL 10mL 0060-062426-1 10/02/2026 0060-062726-1 10/05/2026 0060-070926-1 10/17/2026 0060-071426-1 10/22/2026 0060-071426-2 10/22/2026 0060-072026-1 10/28/2026 0060-072726-1 11/04/2026 0060-072926-1 11/06/2026 0060-073126-1 11/08/2026 0060-080426-1 11/12/2026 The glutathione was distributed to patients nationwide between June 26, 2026, and September 21, 2026. Refer to the photo of the product label below for the location of lot number and beyond use date. G
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does an unclassified recall mean?
The FDA assigns a class once it has assessed the health risk. Until then the recall is listed without one.
Read the official FDA notice · Source record retrieved 2 Oct 2026. This is a company announcement published by the FDA; the FDA has not yet classified the recall. The record is updated when the classification appears in the Enforcement Report. This page reports the record and gives no medical advice.